ATE403153T1 - Test zum direkten nachweisen einer rs virus bezogenen biologischen zelle in einer körperflüssigkeitsprobe - Google Patents

Test zum direkten nachweisen einer rs virus bezogenen biologischen zelle in einer körperflüssigkeitsprobe

Info

Publication number
ATE403153T1
ATE403153T1 AT01978211T AT01978211T ATE403153T1 AT E403153 T1 ATE403153 T1 AT E403153T1 AT 01978211 T AT01978211 T AT 01978211T AT 01978211 T AT01978211 T AT 01978211T AT E403153 T1 ATE403153 T1 AT E403153T1
Authority
AT
Austria
Prior art keywords
biological cell
test
related biological
body fluid
fluid sample
Prior art date
Application number
AT01978211T
Other languages
English (en)
Inventor
Michael Lassen
Morten Breindahl
Original Assignee
Besst Test Aps
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Besst Test Aps filed Critical Besst Test Aps
Application granted granted Critical
Publication of ATE403153T1 publication Critical patent/ATE403153T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/115—Paramyxoviridae, e.g. parainfluenza virus
    • G01N2333/135—Respiratory syncytial virus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT01978211T 2000-10-17 2001-10-12 Test zum direkten nachweisen einer rs virus bezogenen biologischen zelle in einer körperflüssigkeitsprobe ATE403153T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200001549 2000-10-17
US24213200P 2000-10-23 2000-10-23

Publications (1)

Publication Number Publication Date
ATE403153T1 true ATE403153T1 (de) 2008-08-15

Family

ID=26068896

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01978211T ATE403153T1 (de) 2000-10-17 2001-10-12 Test zum direkten nachweisen einer rs virus bezogenen biologischen zelle in einer körperflüssigkeitsprobe

Country Status (9)

Country Link
US (1) US6790611B2 (de)
EP (1) EP1340086B1 (de)
JP (1) JP2004511807A (de)
AT (1) ATE403153T1 (de)
AU (2) AU2002210384B2 (de)
CA (1) CA2463678A1 (de)
DE (1) DE60135147D1 (de)
DK (1) DK1340086T3 (de)
WO (1) WO2002033417A1 (de)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040048274A1 (en) * 2000-10-17 2004-03-11 Morten Breindahl Assay for directly detecting an inflammatory indicator in a body fluid sample
US7754155B2 (en) * 2002-03-15 2010-07-13 Ross Amelia A Devices and methods for isolating target cells
US20090314946A1 (en) * 2002-08-27 2009-12-24 Kimberly-Clark Worldwide, Inc. Membrane-Based Assay Devices that Utilize Time-Resolved Fluorescence
CN104076143B (zh) * 2003-05-02 2017-06-13 安克塞斯生物公司 层析分析系统
US7378285B2 (en) 2003-09-22 2008-05-27 Paul Lambotte Devices for the detection of multiple analytes in a sample
US20060046310A1 (en) * 2004-08-25 2006-03-02 Zong-Li Xia Amplification method for solid phase immunoassays
US7189522B2 (en) 2005-03-11 2007-03-13 Chembio Diagnostic Systems, Inc. Dual path immunoassay device
WO2006098804A2 (en) 2005-03-11 2006-09-21 Chembio Diagnostic Systems, Inc. Dual path immunoassay device
ES2640295T5 (en) 2005-04-04 2025-02-13 Biogen Ma Inc Methods for evaluating an immune response to a therapeutic agent
HUE047230T2 (hu) 2006-02-28 2020-04-28 Biogen Ma Inc Gyulladásos és autoimmun betegségek natalizumabbal való kezelésének módszerei
AU2007224228B2 (en) 2006-03-03 2013-09-19 Biogen Ma Inc. Methods of treating inflammatory and autoimmune diseases with natalizumab
GB0612825D0 (en) * 2006-06-28 2006-08-09 Iti Scotland Ltd Analyte detection
US20110184747A1 (en) * 2006-08-09 2011-07-28 Carmen Bozic Method for distribution of a drug
US20100178652A1 (en) * 2007-01-05 2010-07-15 Litherland Sally A Materials and Methods for the Detection, Prevention and Treatment of Autoimmune Disease
WO2009014787A2 (en) 2007-04-30 2009-01-29 Nanogen, Inc. Multianalyte assay
EP2140265B1 (de) * 2007-03-22 2012-10-31 Scandinavian Micro Biodevices A/S Durchflusssystem, durchflussvorrichtung und verfahren zur durchführung eines tests
EP2716656B1 (de) 2007-06-15 2016-10-12 Xiamen University An Hämagglutinin des Vogelgrippevirus Subtyp H5 bindende monoklonale Antikörper und Verwendung dafür
EP2217925A4 (de) * 2007-12-13 2011-01-19 Beckman Coulter Inc Vorrichtung und verfahren für den nachweis einer zielzelle
US9285361B2 (en) * 2008-07-03 2016-03-15 Johnson & Johnson Ab Method for the analysis of circulating antibodies
JP5575377B2 (ja) * 2008-07-18 2014-08-20 シスメックス株式会社 抗ｒｓウイルスモノクローナル抗体を用いたｒｓウイルス検出用キット及びイムノクロマトグラフィー用試験具、並びに新規な抗ｒｓウイルスモノクローナル抗体
US20100022916A1 (en) 2008-07-24 2010-01-28 Javanbakhsh Esfandiari Method and Apparatus for Collecting and Preparing Biological Samples for Testing
WO2011044553A1 (en) 2009-10-11 2011-04-14 Biogen Idec Ma Inc. Anti-vla-4 related assays
PT2524060T (pt) 2010-01-11 2018-03-28 Biogen Ma Inc Ensaio para a deteção de anticorpos contra o vírus jc
US11287423B2 (en) 2010-01-11 2022-03-29 Biogen Ma Inc. Assay for JC virus antibodies
US8603835B2 (en) 2011-02-10 2013-12-10 Chembio Diagnostic Systems, Inc. Reduced step dual path immunoassay device and method
PT3575792T (pt) 2011-05-31 2023-02-28 Biogen Ma Inc Método de avaliação do risco de lmp
CL2011003002A1 (es) 2011-11-25 2012-05-25 Univ Pontificia Catolica Chile Anticuerpo monoclonal o un fragmento del mismo que se une a la proteina m2-1 del virus respiratorio sincicial (vrs) humano; secuencias nucleotidicas; composicion farmaceutica; metodo de diagnostico de infeccion producida por vrs; kit; y uso de dicho anticuerpo para preparar un medicamento.
EP2902783B1 (de) * 2012-09-28 2017-08-30 Sekisui Medical Co., Ltd. Additiv zur messung einer verdünnten probe in einem reagens einer immunchromatografischen methode ohne verdünnung
EP2936160A1 (de) * 2012-12-20 2015-10-28 Novartis AG Akute nierenläsion
EP3004334A4 (de) 2013-05-28 2016-12-21 Biogen Ma Inc Verfahren zur beurteilung eines pml-risikos
JP6454274B2 (ja) * 2013-06-21 2019-01-16 アルフレッサファーマ株式会社 Ｒｓｖを検出するためのイムノクロマトグラフィー装置
US10260111B1 (en) 2014-01-20 2019-04-16 Brett Eric Etchebarne Method of detecting sepsis-related microorganisms and detecting antibiotic-resistant sepsis-related microorganisms in a fluid sample
CA2944488C (en) 2014-04-02 2023-03-21 Chembio Diagnostic Systems, Inc. Immunoassay utilizing trapping conjugate
US20160116466A1 (en) 2014-10-27 2016-04-28 Chembio Diagnostic Systems, Inc. Rapid Screening Assay for Qualitative Detection of Multiple Febrile Illnesses
JP2016164553A (ja) * 2015-02-27 2016-09-08 株式会社リコー 標的検査装置、標的検査キット、標的検査方法、転写媒体、及び標的検査装置の製造方法
US9867250B1 (en) 2015-04-20 2018-01-09 The Arizona Board Of Regents On Behalf Of The University Of Arizona System having a configurable pico-second pulsed LED driver circuit and photomultiplier tube biasing and gating circuits for real-time, time-resolved transient recording of fluorescence
EP3332255B1 (de) 2015-08-06 2020-06-17 Lia Diagnostics, Inc. Wasserdispergierbare tests
EP3837275A4 (de) 2018-06-29 2022-07-13 Fred Hutchinson Cancer Center Zellgespeicherte barcodierte tiefe mutationsscannende bibliotheken und deren verwendungen
EP3848389A4 (de) 2018-09-03 2022-04-13 Pontificia Universidad Católica De Chile Spezifischer monoklonaler antikörper gegen das n-antigen des humanen respiratorischen synzytialvirus (hrsv) zur behandlung von infektionen, deren nachweis und diagnose
JP7808851B2 (ja) * 2020-02-25 2026-01-30 ヘリックスバインド・インコーポレイテッド 流体システムのための試薬キャリア
JP2023518608A (ja) * 2020-03-26 2023-05-02 セキュリティ マターズ リミテッド Ｘｒｆによるウイルスの検出のための装置および方法
US20210325380A1 (en) * 2020-04-20 2021-10-21 EnLiSense, LLC Disease diagnostics using a multi-configurable sensing array

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4452773A (en) * 1982-04-05 1984-06-05 Canadian Patents And Development Limited Magnetic iron-dextran microspheres
US4663277A (en) * 1983-05-20 1987-05-05 Profile Diagnostic Sciences Inc. Virus detection method and materials
ATE161963T1 (de) 1989-06-06 1998-01-15 Ampcor Inc Reagenziensatz für immunoassay
CA2023850A1 (en) * 1989-09-28 1991-03-29 Randal A. Hoke Stabilizing reagent for membrane immunoassay
US5075078A (en) * 1989-10-05 1991-12-24 Abbott Laboratories Self-performing immunochromatographic device
DK130991D0 (da) * 1991-07-04 1991-07-04 Immunodex K S Polymere konjugater
WO1993002359A1 (en) * 1991-07-19 1993-02-04 Assay Research, Inc. Method and kit for measuring endogenous cytokines
US5369036A (en) * 1992-07-02 1994-11-29 Becton, Dickinson And Company Enhancement of signal in immunoassays using microparticles which contain different detectable substances
DK0671927T3 (da) * 1992-09-16 2003-04-22 Us Gov Health & Human Serv Neutraliserende humane monoklonale antistoffer mod respiratorisk syncytialvirus
ATE178906T1 (de) * 1994-08-25 1999-04-15 Stichting Inst Dierhouderij Antigene peptide abgeleitet vom g-protein des rsv (respiratorisches synzytialvirus) für die typen- und subtypen spezifische diagnose einer rsv- infektionen
US6083708A (en) * 1995-08-11 2000-07-04 Dade Behring Inc. Polypeptide: dendrimer complexes
AU7081796A (en) * 1995-10-03 1997-04-28 Universite De Montreal Diagnostic kit for bovine syncytial respiratory virus
JP3601972B2 (ja) * 1998-05-14 2004-12-15 松下電器産業株式会社 色素標識タンパク質複合体およびその製造方法
US6451980B1 (en) * 1997-02-26 2002-09-17 Ban-An Khaw Signal enhancement of bispecific antibody-polymer probe for immunoassay use
KR100523685B1 (ko) * 1997-08-04 2005-10-26 가부시끼가이샤 센탈 세메 가가꾸 겐꾸쇼 Ｃ형 간염 바이러스의 코어 영역의 아미노산 서열을 인지하는 모노클로날 항체

Also Published As

Publication number Publication date
EP1340086B1 (de) 2008-07-30
JP2004511807A (ja) 2004-04-15
US6790611B2 (en) 2004-09-14
US20020081573A1 (en) 2002-06-27
DK1340086T3 (da) 2008-12-01
AU2002210384B2 (en) 2006-10-19
AU1038402A (en) 2002-04-29
EP1340086A1 (de) 2003-09-03
WO2002033417A1 (en) 2002-04-25
DE60135147D1 (de) 2008-09-11
CA2463678A1 (en) 2002-04-25

Similar Documents

Publication Publication Date Title
DE60135147D1 (de) Nen biologischen zelle in einer körperflüssigkeitsprobe
DE50113548D1 (de) Verfahren zum Nachweis von Influenza A/B-Viren in Speichel
ATE556030T1 (de) Ultrasensitiver nachweis von analyten
AU2003243558A1 (en) Test strip for detection of analyte and methods of use
EP0805215A3 (de) Diagnostische Methoden und Proben
ATE515693T1 (de) Nachweis einer zielsubstanz in einer probe
WO2001038873A3 (en) Devices and methods for detecting analytes using electrosensor having capture reagent
WO2002033410A3 (en) Microvolume immunoabsorbant assays with amplified electrochemical detection
ATE386815T1 (de) Methoden und syteme zur überwachung intrazellulärer bindereaktionen
WO2004055205A3 (en) Biological reagents and methods to verify the efficiency of sample preparation and nucleic acid amplification and/or detection
JP2004503760A5 (de)
ATE423972T1 (de) Vorrichtung und verfahren um gleichzeitig verschiedene antikörper und antigene nachzuweisen in klinischen, nahrungsmittel- und umwelt-proben
TW200720441A (en) New labelling strategies for the sensitive detection of analytes
AU6775201A (en) Improved capture and detection of target nucleic acid in dipstick assays
BR0206145A (pt) Sistema de teste indicador com tira reagente para uso em lìquidos para a detecção e/ou determinação de sequências especìficas de ácido nucléico
DE69737628D1 (de) Nukleinsäureprimer und -sonden zur detektion onkogener humaner papillomaviren
DE60225802D1 (de) Verfahren und gerät zum nachweis des gesamten proteingehaltes bei niedrigen ph-werten
TR200103011T2 (tr) Bulaşıcı sünger tipi ansefalopatilerinin teşhisine yönelik metod.
DE60333876D1 (de) Methoden zum Nachweis Analyten in Proben
WO2007001737A3 (en) Methods and compositions for detecting herpes simplex virus type 2
WO2006099537A3 (en) The use of antibody-surrogate antigen systems for detection of analytes
DE60038557D1 (en) Assay
WO2002004122A3 (en) Improved stability of hybridisation interactions in dipstick assays
DE50203136D1 (de) Verfahren zum Nachweis von Analyten in Proben mittels Analysenelementen
WO2003014695A3 (de) Biosensor und verfahren zum erfassen von makromolekularen biopolymeren mittels mindestens einer einheit zum immobilisieren von makromolekularen biopolymeren

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties